Heron Therapeutics (HRTX) vs Stablecoin Development (SDEV)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 11, 2026.
Summary
Heron Therapeutics (HRTX) has outperformed Stablecoin Development (SDEV) over the past year, losing 68.3% versus a loss of 76.1%. Over five years, HRTX leads with a -96.2% price change compared with -100.0% for SDEV. Stablecoin Development is the larger company by market cap ($79.7 million vs $77.1 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HRTX | SDEV |
|---|---|---|
| Share price | $0.4061 | $1.54 |
| Market cap | $77.10M | $79.70M |
| 1-day change | +13.37% | -22.61% |
| YTD return | -68.76% | -94.54% |
| 1-year return | -68.27% | -76.12% |
| 5-year return | -96.17% | -99.95% |
| EPS (TTM) | $-0.18 | $-21.13 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.58 | $99.75 |
| 52-week low | $0.26 | $0.78 |
| Distance from 52-week high | -74.30% | -98.46% |
| Analyst consensus | none | — |
| Avg. price target upside | +1623.71% | — |
| Average volume | 2.60M | 11.99M |
| Shares outstanding | 189.85M | 51.75M |
| Employees | 128 | 2 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Heron Therapeutics
HRTX stock →Heron Therapeutics, Inc., a commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration.
Health Care · Biotechnology: Pharmaceutical Preparations · 128 employees
About Stablecoin Development
SDEV stock →Stablecoin Development Corporation engages in the accumulation and holding of digital assets for participation in blockchain-based networks. The company focuses on the accumulation, holding, and deployment of SKY, a protocol token of the decentralized Sky Protocol.
Health Care · Biotechnology: Pharmaceutical Preparations · 2 employees
HRTX vs SDEV FAQ
Which is bigger, Heron Therapeutics or Stablecoin Development?
Stablecoin Development (SDEV) is larger, with a market capitalization of $79.70M compared with $77.10M for Heron Therapeutics (HRTX).
Which stock has performed better over the past year, HRTX or SDEV?
HRTX returned -68.27% over the past 12 months, compared with -76.12% for SDEV (price return, excluding dividends). Past performance does not predict future results.
Are Heron Therapeutics and Stablecoin Development in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.